Quanterix

Q: Where is Quanterix headquartered?

Quanterix is headquartered in Billerica, Massachusetts, a hub for biotechnology and life sciences companies in the United States. The company has been operating since 2007, making it a relatively established player in the field of ultrasensitive biomarker detection technologies.

Q: How many employees does Quanterix have?

Quanterix employes over 300 talented individuals dedicated to advancing the field of ultrasensitive biomarker detection. The company has steadily grown its headcount since its inception in 2007, reflecting the increasing demand for its innovative technologies and the expansion of its global footprint.

169 cited products 1 167 protocol citations

Quanterix is a leading provider of innovative research solutions and tools for the scientific community.
The company's products power a wide range of research protocols, enabling researchers to explore the impact of Quanterix technologies across scientific publications, preprints, and patents.
Quanterix offers a diverse portfolio of equipment, consumables, reagents, and software designed to support advanced research workflows.
Its analytical platforms and assays are used in a variety of fields, including neurology, immunology, oncology, and cardiovascular research, among others.
The company's products leverage cutting-edge technologies, such as digital biomarker detection, to deliver precise and reliable data that drives scientific progress.
Researchers can access insights into citation trends and total citations for Quanterix products across the PubCompare database, helping them make informed decisions about the tools they use.
With a focus on delivering innovative solutions that address the evolving needs of the research community, Quanterix is committed to empowering scientists to push the boundaries of discovery and advance our understanding of complex biological systems.

169 products from Quanterix

Simoa hd 1 analyzer by Quanterix

Cited in 115 protocols

Sourced in United States

The Simoa HD-1 Analyzer is a compact benchtop instrument designed for the detection and quantification of low-abundance proteins and other analytes in biological samples. The core function of the Simoa HD-1 Analyzer is to perform single-molecule array (Simoa) technology, which enables the detection of target molecules at ultra-low concentrations.

Hd 1 analyzer by Quanterix

Cited in 59 protocols

Sourced in United States, Sweden

The HD-1 Analyzer is a benchtop instrument designed for the quantitative analysis of protein biomarkers. The device utilizes Quanterix's proprietary Simoa technology to enable the detection and measurement of low-concentration analytes in biological samples with high sensitivity and specificity.

Simoa hd x analyzer by Quanterix

Cited in 54 protocols

Sourced in United States

The Simoa HD-X analyzer is a compact, automated immunoassay platform developed by Quanterix. It is designed to perform highly sensitive and precise quantification of low-abundance protein biomarkers from small sample volumes. The Simoa HD-X utilizes proprietary Single Molecule Array (Simoa) technology to achieve femtomolar (10^-15 M) level detection limits, enabling the measurement of analytes that were previously undetectable with traditional immunoassays.

Hd x analyzer by Quanterix

Cited in 48 protocols

Sourced in United States

The HD-X Analyzer is a lab equipment product from Quanterix. It is designed to perform precise and sensitive measurements of biomarkers in biological samples.

Simoa nf light advantage kit by Quanterix

Cited in 44 protocols

Sourced in United States

The Simoa NF-Light Advantage Kit is a lab equipment product manufactured by Quanterix. It is designed to detect and quantify Neurofilament Light (NF-Light) protein levels in biological samples using the Simoa technology.

Simoa hd 1 by Quanterix

Cited in 39 protocols

Sourced in United States

The Simoa HD-1 is a high-definition digital immunoassay platform developed by Quanterix. It provides a sensitive and accurate method for detecting and quantifying low-abundance protein biomarkers in biological samples.

Nf light advantage kit by Quanterix

Cited in 37 protocols

Sourced in United States

The NF-Light Advantage Kit is a lab equipment product offered by Quanterix. It is designed for the quantitative measurement of neurofilament light (NF-Light) protein levels. The kit provides the necessary components and reagents to perform these NF-Light protein assays.

Simoa platform by Quanterix

Cited in 35 protocols

Sourced in United States

The Simoa platform is a high-sensitivity digital immunoassay system developed by Quanterix. It is designed to quantify low-abundance protein biomarkers in biological samples with high precision and sensitivity.

Simoa hd x by Quanterix

Cited in 27 protocols

Sourced in United States

The Simoa HD-X is a high-definition digital immunoassay analyzer developed by Quanterix. It is designed to detect and quantify low-abundance proteins and other analytes with high sensitivity and specificity. The Simoa HD-X uses Quanterix's proprietary Single Molecule Array (Simoa) technology to enable the detection of individual protein molecules, providing a powerful tool for researchers and clinicians.

Simoa hd 1 platform by Quanterix

Cited in 26 protocols

Sourced in United States

The Simoa HD-1 platform is a highly sensitive and precise immunoassay system designed for the detection and quantification of various biomolecules, such as proteins and nucleic acids. The platform utilizes single-molecule array (Simoa) technology to enable the measurement of analytes at exceptionally low concentrations, providing enhanced sensitivity compared to conventional immunoassay methods.

Company FAQ

Where is Quanterix headquartered?

What types of equipment and research fields does Quanterix cater to?

Quanterix's flagship product is the Simoa platform, which is used for ultra-sensitive detection of protein biomarkers. This technology is widely adopted across various research fields, including neurology, immunology, oncology, and cardiology. Researchers leverage Simoa to gain unprecedented insights into disease mechanisms and develop more accurate diagnostic and prognostic tools.

How can PubCompare.ai help researchers using Quanterix products?

PubCompare.ai is a unique tool developed by Quanterix to help researchers locate published protocols and applications using specific Simoa assays and products. This improves reproducibility, reduces mistakes, and minimizes inherent wastage by allowing scientists to quickly identify best practices and learn from the experiences of their peers. By streamlining the research process, PubCompare.ai empowers Quanterix customers to maximize the value of their investments in ultrasensitive detection technologies.

How many employees does Quanterix have?

What is a fun fact about Quanterix?

One intriguing fact about Quanterix is that the company's name is derived from the term "quanta", which refers to the smallest possible discrete unit of any physical property, such as energy or matter. This aligns with Quanterix's mission to develop technologies capable of detecting the most minuscule biological signals, enabling breakthroughs in early disease detection and personalized medicine.

Is this your company ?

Claim your company profile and access business tools

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!